|
C18ORF10 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.299800E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.228000E-01 |
| Normal-vs-Stage2 |
3.307000E-01 |
| Normal-vs-Stage3 |
6.530600E-01 |
| Normal-vs-Stage4 |
4.212000E-01 |
| Stage1-vs-Stage2 |
3.838400E-02 |
| Stage1-vs-Stage3 |
4.203600E-01 |
| Stage1-vs-Stage4 |
7.490500E-02 |
| Stage2-vs-Stage3 |
1.817050E-01 |
| Stage2-vs-Stage4 |
7.376200E-01 |
| Stage3-vs-Stage4 |
1.998400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.816200E-01 |
| Normal-vs-AfricanAmerican |
4.435500E-03 |
| Normal-vs-Asian |
9.508200E-01 |
| Caucasian-vs-AfricanAmerican |
4.501800E-03 |
| Caucasian-vs-Asian |
4.455600E-01 |
| AfricanAmerican-vs-Asian |
5.335400E-03 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.208200E-01 |
| Normal-vs-Female |
4.616200E-01 |
| Male-vs-Female |
6.014000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.815420E-01 |
| Normal-vs-Age(41-60Yrs) |
9.143800E-01 |
| Normal-vs-Age(61-80Yrs) |
8.619800E-01 |
| Normal-vs-Age(81-100Yrs) |
4.637400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.483020E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.226560E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.581400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.639000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.079400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.060000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.387800E-01 |
| Classical-VS-Follicular |
7.220900E-03 |
| Classical-VS-Other |
9.915000E-01 |
| Classical-VS-Normal |
1.951430E-01 |
| Tall-VS-Follicular |
1.118840E-01 |
| Tall-VS-Other |
8.725000E-01 |
| Tall-VS-Normal |
4.987800E-01 |
| Follicular-VS-Other |
3.982200E-01 |
| Follicular-VS-Normal |
2.509400E-01 |
| Other-VS-Normal |
5.616200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.925400E-01 |
| Normal-vs-N1 |
2.900400E-01 |
| N0-vs-N1 |
3.116400E-01 |
|
|
